A paradox: the 5-HT₂-receptor antagonist ketanserin restores the 5-HT-induced contraction depressed by methysergide in large coronary arteries of calf: allosteric regulation of 5-HT₂-receptorsKAUMANN, A. J; FRENKEN, M.Naunyn-Schmiedeberg's archives of pharmacology. 1985, Vol 328, Num 3, pp 295-300, issn 0028-1298Article

Receptor specificity of the 5HT₂ receptor antagonist, LY 53857COHEN, M. L; COLBERT, W; WITTENAUER, L. A et al.Drug development research. 1985, Vol 5, Num 4, pp 313-321, issn 0272-4391Article

PH-dependent modulation of agonist interactions with ˚³H]-ketanserin-labelled S₂ serotonin receptorsBATTAGLIA, G; SHANNON, M; BORGUNDVAAG, B et al.Life sciences (1973). 1983, Vol 33, Num 20, pp 2011-2016, issn 0024-3205Article

N₁-methyl-2-[¹²⁵I]LSD([¹²⁵I]MIL), a preferred ligand for serotonin 5-HT₂ receptorsHOFFMAN, B. J; KARPA, M. D; LEVER, J. R et al.European journal of pharmacology. 1985, Vol 110, Num 1, pp 147-148, issn 0014-2999Article

7-Amino-8-[¹²⁵I]-ketanserin ([¹²⁵I]AMIK), a highly sensitive, serotonin-S₂ receptor ligandWOUTERS, W; VAN DUN, J; LADURON, P. M et al.Biochemical pharmacology. 1986, Vol 35, Num 19, pp 3199-3202, issn 0006-2952Article

Platelet α₂-adrenergic receptors in depressionKAFKA, M. S; PAUL, S. M.Archives of general psychiatry. 1986, Vol 43, Num 1, pp 91-95, issn 0003-990XArticle

Human platelet 5-HT₂ receptor binding sites re-evaluated : a criticism of recurrent techniquesSTECKLER, T; RÜGGEBERG-SCHMIDT, K; MÜLLER-OERLINGHAUSEN, B et al.Journal of neural transmission. 1993, Vol 92, Num 1, pp 11-24, issn 0300-9564Article

5HT₂-receptors and serotonin release : their role in human platelet aggregationCERRITO, F; LAZZARO, M. P; GAUDIO, E et al.Life sciences (1973). 1993, Vol 53, Num 3, pp 209-215, issn 0024-3205Article

Species differences in the pharmacology of the 5-hydroxytryptamine₂ receptor : strucutally specific differentiation by ergolines and tryptaminesNELSON, D. L; LUCAITES, V. L; AUDIA, J. E et al.The Journal of pharmacology and experimental therapeutics. 1993, Vol 265, Num 3, pp 1272-1279, issn 0022-3565Article

Characteristics of ³H-ketanserin binding to human platelet membraneOHSUKA, N; OKANO, T; KANNO, T et al.Neurosciences (Okayama). 1992, Vol 18, Num 2, pp 105-112, issn 0388-7448Article

Increase in serotonin₂ receptor density in rat cerebral cortex slices by stimulation of beta-adrenergic receptorsSCOTT, J. A; CREWS, F. T.Biochemical pharmacology. 1985, Vol 34, Num 9, pp 1585-1588, issn 0006-2952Article

Behavioural and biochemical evidence that glucocorticoids are not involved in DOI-elicited 5-HT₂ receptor down-regulationCHAOULOFF, F; BAUDRIE, V; COUPRY, I et al.European journal of pharmacology. 1993, Vol 249, Num 1, pp 117-120, issn 0014-2999Article

Target size analysis of serotonin 5-HT₁ and 5-HT₂ receptors in bovine brain membranesNISHINO, N; TANAKA, C.Life sciences (1973). 1985, Vol 37, Num 12, pp 1167-1174, issn 0024-3205Article

Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the ratRUPNIAK, N. M. J; HALL, M. D; MANN, S et al.Biochemical pharmacology. 1985, Vol 34, Num 15, pp 2755-2763, issn 0006-2952Article

³H-ketanserin and ³H-imipramide binding to platelets from humansOKANO, T; TOSHIMA, T; OHSUKA, Y et al.Neurosciences (Okayama). 1992, Vol 18, Num AVR, pp P37-P40, issn 0388-7448, SUPConference Paper

Ketanserin (S₂-receptor blocking agent), platelet activity and chronic alcoholismSANTINI, P; CECCANTI, M; DE LORENZO, A et al.International journal of clinical pharmacology research. 1986, Vol 6, Num 1, pp 73-76, issn 0251-1649Article

Characterization of the 5-HT_1B recognition site in rat brain: binding studies with (-)[¹²⁵I]iodocyanopindololHOYER, D; ENGEL, G; KALKMAN, H. O et al.European journal of pharmacology. 1985, Vol 118, Num 1-2, pp 1-12, issn 0014-2999Article

Serotonin 5-HT2 receptor binding on blood platelets. A peripheral marker for depression?BIEGON, A; WEIZMAN, A; KARP, L et al.Life sciences (1973). 1987, Vol 41, Num 22, pp 2485-2492, issn 0024-3205Article

Homologoud desensitization of serotonin 5-HT₂ receptor-stimulated intracellular calcium mobilization in C6BU-1 glioma cells via a mechanism involving a calmodulin pathwayKAGAYA, A; MIKUNI, M; MURAOKA, S.-I et al.Journal of neurochemistry. 1993, Vol 61, Num 3, pp 1050-1056, issn 0022-3042Article

Immunocytochemical localization and description of neurons expressing serotonin₂ receptors in the rat brainMORILAK, D. A; GARLOW, S. J; CIARANELLO, R. D et al.Neuroscience. 1993, Vol 54, Num 3, pp 701-717, issn 0306-4522Article

5-HT₂ Serotonin receptor on blood platelet of migraine patientsGOVITRAPONG, P; LIMTHAVON, C; SRIKIETKHACHORN, A et al.Headache. 1992, Vol 32, Num 10, pp 480-484, issn 0017-8748Article

Role and localization of serotonin-5HT₂ receptorsLEYSEN, J. E; SCHOTTE, A.Progress in histochemistry and cytochemistry. 1992, Vol 26, Num 1-4, pp 241-249, issn 0079-6336Article

5-HT₂ receptor antagonism in dysthymic disorder : a double-blind placebo-controlled study with ritanserinBERSANI, G; POZZI, F; MARINI, S et al.Acta psychiatrica Scandinavica. 1991, Vol 83, Num 4, pp 244-248, issn 0001-690X, 5 p.Article

Pharmacokinetics of ritanserin in patients undergoing hemodialysisZAZGORNIK, J; KUSKA, J; KOKOT, F et al.Journal of clinical pharmacology. 1991, Vol 31, Num 7, pp 657-661, issn 0091-2700Article

Pharmacological validation of ritanserin and risperidone in the drug discrimination test procedure in the ratMEERT, T. F; DE HAES, P. L. A. J; VERMOTE, P. C. M et al.Drug development research. 1990, Vol 19, Num 4, pp 353-373, issn 0272-4391, 21 p.Article